微創腦科學(02172.HK)發佈盈喜:預計年度營收同比增長36%-41%,海外業務收入暴增逾32倍
格隆匯1月13日丨微創腦科學(02172.HK)公佈,預期集團於截至2022年12月31日止年度錄得收入約為人民幣5.20億元至人民幣5.40億元之間,較2021年度增長約36%至41%;其中,集團海外業務收入首次突破人民幣2000萬元,較2021年度增長超過3,200%;及經調整淨溢利約為人民幣1億元至人民幣1.20億元之間,較2021年度增長約15%至38%。
董事會認為前述集團收入及盈利水平的預期增幅主要歸功於下列原因:(i)集團近年上市的主要新產品(包括NUMEN®可解脱栓塞彈簧圈、Bridge®椎動脈雷帕黴素靶向洗脱支架系統及U-track®顱內支撐導管系統等)加速推進招標入院,收入快速放量;(ii)集團市場份額領先產品(包括Tubridge®血流導向密網支架和Asahi®系列神經血管導絲等)通過整合渠道資源及持續開拓下沉市場,不斷鞏固競爭優勢,保持良好增長態勢;(iii)集團海外業務收入在2022年度實現突破性增長,超過人民幣20百萬元。2022年度,集團產品新增在六個海外國家和地區實現商業化,包括美國、韓國、巴西及歐洲地區;及(iv)集團2022年度新獲批產品(包括Neurohawk®顱內取栓支架、Diveer®顱內球囊擴張導管等)開始商業化,貢獻集團收入增量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.